意大利病毒学会关于人乳头瘤病毒检测及宫颈癌预防疫苗接种的指南
Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.
作者信息
Barzon Luisa, Giorgi Colomba, Buonaguro Franco M, Palù Giorgio
机构信息
Department of Histology, Microbiology, and Medical Biotechnologies, University of Padova, 35121 Padova, Italy.
出版信息
Infect Agent Cancer. 2008 Dec 16;3:14. doi: 10.1186/1750-9378-3-14.
Abstract
OBJECTIVE
To provide guidelines for health-care providers on strategies for cervical cancer prevention based on HPV testing and anti-HPV vaccination.
OUTCOMES
Overall efficacy of different preventive strategies, assessing reduction in the incidence of invasive cervical cancer and precancerous lesions.
EVIDENCE
Medline and the Cochrane Database were searched for articles in English on subjects related to HPVs, HPV diagnosis, HPV anogenital lesions, cervical cancer, HPV testing, and HPV vaccines, in order to elaborate an up-dated document. Relevant Italian Government publications and position papers from appropriate health and family planning organizations were also reviewed.
VALUES
The quality of the evidence and ranking of recommendations for practice were rated using criteria defined by SIV, which were adapted from the Canadian Task Force on Preventive Health Care.
摘要
目的
为医疗保健提供者提供基于人乳头瘤病毒（HPV）检测和抗HPV疫苗接种的宫颈癌预防策略指南。
结果
不同预防策略的总体疗效，评估浸润性宫颈癌和癌前病变发病率的降低情况。
证据
检索了医学文献数据库（Medline）和考科蓝协作网数据库（Cochrane Database），查找有关HPV、HPV诊断、HPV肛门生殖器病变、宫颈癌、HPV检测和HPV疫苗的英文文章，以编写一份最新文件。还查阅了意大利政府的相关出版物以及适当的卫生和计划生育组织的立场文件。
价值观
使用意大利预防医学协会（SIV）定义的标准对证据质量和实践建议等级进行评级，该标准改编自加拿大预防性医疗保健工作组的标准。
相似文献
1
Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.意大利病毒学会关于人乳头瘤病毒检测及宫颈癌预防疫苗接种的指南
Infect Agent Cancer. 2008 Dec 16;3:14. doi: 10.1186/1750-9378-3-14.
2
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.不同人乳头瘤病毒（HPV）疫苗类型及接种程序对预防女性和男性HPV相关疾病的比较。
Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD013479. doi: 10.1002/14651858.CD013479.
3
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].[卫生技术评估报告：基于人乳头瘤病毒DNA的宫颈癌前病变初筛]
Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72.
4
No. 385-Indications for Pelvic Examination.第385号——盆腔检查的适应症
J Obstet Gynaecol Can. 2019 Aug;41(8):1221-1234. doi: 10.1016/j.jogc.2018.12.007.
5
SOGC clinical practice guidelines: Canadian contraception consensus.加拿大妇产科医师协会临床实践指南：加拿大避孕共识
J Obstet Gynaecol Can. 2004 Mar;26(3):219-96.
6
Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.国家免疫咨询委员会关于人乳头瘤病毒（HPV）疫苗的最新建议摘要：HPV免疫接种程序中九价人乳头瘤病毒（HPV）各剂次之间的最短间隔时间。
Can Commun Dis Rep. 2016 Jul 7;42(7):149-151. doi: 10.14745/ccdr.v42i07a03.
7
Canadian Contraception Consensus (Part 2 of 4).加拿大避孕共识（共四部分，第二部分）
J Obstet Gynaecol Can. 2015 Nov;37(11):1033-9. doi: 10.1016/s1701-2163(16)30054-8.
8
Canadian Contraception Consensus (Part 1 of 4).加拿大避孕共识（共4部分，第1部分）
J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0.
9
Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.卫生保健专业人员是否准备好实施人乳头瘤病毒检测？人乳头瘤病毒检测在原发性宫颈癌筛查中可接受性的社会心理决定因素综述。
J Womens Health (Larchmt). 2020 Mar;29(3):390-405. doi: 10.1089/jwh.2019.7678. Epub 2019 Sep 3.
10
[Challenges in the implementation of HPV vaccination for cancer prevention].
Rev Prat. 2019 May;69(5):529-534.
引用本文的文献
1
Human Papillomavirus (HPV) Prevalence and Type Distribution in Urban Areas of Malaysia.马来西亚城市地区的人乳头瘤病毒（HPV）流行率和型别分布。
Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2969-2976. doi: 10.31557/APJCP.2021.22.9.2969.
2
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.在 VALGENT-3 框架内对 AnyPlex II HPV HR 检测分析进行临床和分析评估。
J Clin Microbiol. 2018 Oct 25;56(11). doi: 10.1128/JCM.01176-18. Print 2018 Nov.
3
Integration of human papillomavirus type 16 in cervical cancer cells.人乳头瘤病毒16型在宫颈癌细胞中的整合。
Open Med (Wars). 2014 Sep 25;10(1):1-7. doi: 10.1515/med-2015-0001. eCollection 2015.
4
Rome Consensus Conference - statement; human papilloma virus diseases in males.罗马共识会议声明：男性的人乳头瘤病毒疾病。
BMC Public Health. 2013 Feb 7;13:117. doi: 10.1186/1471-2458-13-117.
5
Prevalence and distribution of human papillomavirus infection in Korean women as determined by restriction fragment mass polymorphism assay.基于限制性片段质量多态性分析的韩国女性人乳头瘤病毒感染的流行率和分布。
J Korean Med Sci. 2012 Sep;27(9):1091-7. doi: 10.3346/jkms.2012.27.9.1091. Epub 2012 Aug 22.
6
Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).多中心前瞻性队列研究的原理和设计，用于评估和监测高危女性的 HPV 感染和相关宫颈疾病（VALHIDATE 研究）。
BMC Cancer. 2012 May 30;12:204. doi: 10.1186/1471-2407-12-204.
7
Prevalence of human papillomavirus infection in women in Benin, West Africa.贝宁（西非国家）女性人乳头瘤病毒感染的流行情况。
Virol J. 2011 Nov 10;8:514. doi: 10.1186/1743-422X-8-514.
8
Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.人乳头瘤病毒与宫颈癌：改善预防措施的生物标志物。
Future Microbiol. 2011 Sep;6(9):1083-98. doi: 10.2217/fmb.11.87.
9
Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.比较 Abbott Realtime High Risk HPV 检测与杂交捕获 2 在基于人群的宫颈癌筛查中的临床和分析性能。
J Clin Microbiol. 2011 May;49(5):1721-9. doi: 10.1128/JCM.00012-11. Epub 2011 Mar 23.
10
Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of Italy.意大利南部女性人乳头瘤病毒类型分布及其与细胞组织学模式的相关性
Infect Dis Obstet Gynecol. 2009;2009:198425. doi: 10.1155/2009/198425. Epub 2010 Jan 24.
本文引用的文献
1
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.利用p16-INK4A过表达提高人乳头瘤病毒检测的特异性：NTCC随机对照试验的一项嵌套子研究
Lancet Oncol. 2008 Oct;9(10):937-45. doi: 10.1016/S1470-2045(08)70208-0. Epub 2008 Sep 8.
2
Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy.意大利南部西西里岛年轻女性中生殖器人乳头瘤病毒感染及基因型的流行情况
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2002-6. doi: 10.1158/1055-9965.EPI-08-0180.
3
Prophylactic HPV vaccines: new interventions for cancer control.预防性人乳头瘤病毒疫苗：癌症控制的新干预措施。
Vaccine. 2008 Nov 18;26(49):6244-57. doi: 10.1016/j.vaccine.2008.07.056. Epub 2008 Aug 9.
4
Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark.在丹麦引入人乳头瘤病毒（HPV）疫苗接种计划之前，基于人群的HPV在女性中的患病率、类型和年龄特异性分布情况。
Int J Cancer. 2008 Oct 15;123(8):1864-70. doi: 10.1002/ijc.23712.
5
A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.人乳头瘤病毒16/18 AS04佐剂宫颈癌疫苗对致癌性人乳头瘤病毒的交叉保护作用综述：病毒学和临床终点的重要性及其对宫颈癌预防大规模疫苗接种的影响
Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S18-25. doi: 10.1016/j.ygyno.2008.06.027. Epub 2008 Jul 23.
6
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types.未充分诊断的人乳头瘤病毒类型的分子流行病学及致病潜力
BMC Microbiol. 2008 Jul 4;8:112. doi: 10.1186/1471-2180-8-112.
7
Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study.法国低级别鳞状上皮内病变中人乳头瘤病毒基因型分布及其与CIN2/3和浸润性宫颈癌的比较：EDiTH III研究
Gynecol Oncol. 2008 Aug;110(2):179-84. doi: 10.1016/j.ygyno.2008.04.012. Epub 2008 Jun 2.
8
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.一项随机对照试验的招募结果，该试验比较了单纯人乳头瘤病毒检测与传统细胞学检查作为主要宫颈癌筛查测试的效果。
J Natl Cancer Inst. 2008 Apr 2;100(7):492-501. doi: 10.1093/jnci/djn065. Epub 2008 Mar 25.
9
Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.92种单克隆抗体与15种人乳头瘤病毒类型的反应模式
J Gen Virol. 2008 Jan;89(Pt 1):117-129. doi: 10.1099/vir.0.83145-0.
10
The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening: a blind revision of all histologic lesions found in the NTCC trial.
Am J Clin Pathol. 2008 Jan;129(1):75-80. doi: 10.1309/EWYGWFRRM8798U5P.
Zotero 插件